Cough News and Research

RSS

Parainfluenza virus 5 may serve as foundation for next breakthrough in human vaccine development

Researchers at the University of Georgia have discovered that a virus commonly found in dogs may serve as the foundation for the next great breakthrough in human vaccine development.

28 Nov 2012

Chronic suppurative lung disease: an interview with Dr Robyn Marsh

Chronic suppurative lung disease, or CSLD, is used to describe a range of lung diseases characterised by a chronic wet cough and progressive lung damage. We are interested in the non-cystic fibrosis forms of the disease with a focus on bronchiectasis – the severe form of CSLD.

26 Nov 2012

FDA grants Seattle Genetics orphan drug designation for ADCETRIS to treat mycosis fungoides

Seattle Genetics, Inc. announced today that ADCETRIS (brentuximab vedotin) has been granted orphan drug designation by the U.S. Food and Drug Administration (FDA) for the treatment of mycosis fungoides (MF). MF is the most common type of cutaneous T-cell lymphoma (CTCL).

26 Nov 2012

State roundup: Calif. schedules health care special session; Fla. to boost Medicaid payment rates

California's legislative special session on health care won't take place until January, according to officials at the California Health and Human Services agency. ... The session was expected to be convened in December. The special session will be held concurrently with the regular legislative session that begins Jan. 7.

22 Nov 2012

Acute cough should raise asthma alarm

Around one-fifth of patients consulting their primary care physician for acute cough could have undiagnosed asthma or chronic obstructive pulmonary disease, show the results of a pan-European study.

20 Nov 2012

Strep detection tests may miss sore throat-causing bacterial strains

Rapid streptococcal antigen detection tests, which are widely used to detect non-group A Lancefield beta-hemolytic streptococci in many developed countries, may be missing clinically important streptococci, say researchers.

19 Nov 2012

Simple ways to reduce risk of lung cancer

More than an estimated 160,000 people in the United States will die from lung cancer this year, making it the country's leading cause of cancer death. According to the National Cancer Institute, it surpassed breast cancer as the number one killer in women back in 1987. It causes more deaths than colon, breast and prostate cancer combined, according to the American Lung Association. Bruce Johnson, MD, the director of the Lowe Center for Thoracic Oncology at Dana-Farber Cancer Institute, sorts out the facts about lung cancer and offers simple ways to reduce risk.

15 Nov 2012

Fevers can be helpful as a child battles an illness

For many parents discovering their child has a fever can be unnerving. It's one of the most common reasons parents call their doctor or bring their child in for medical care. Fevers are just a natural part of many illnesses and, in fact, can be helpful as a child battles an illness.

15 Nov 2012

Minor symptoms a big deal in nasal polyposis

Asthma does not have any significant influence on quality of life among patients with nasal polyposis, but it may increase the intensity of individual minor symptoms such as headache, or fullness in the ears, report researchers.

14 Nov 2012

Hormonal component to respiratory symptoms in women

Changes in respiratory symptoms in women may be governed partly by their menstrual cycles, research suggests.

13 Nov 2012

Respiratory symptoms differ significantly during different stages of the menstrual cycle

Respiratory symptoms vary significantly during different stages of the menstrual cycle, with higher frequencies during the mid-luteal to mid-follicular stages, according to a new study.

9 Nov 2012

Treatment with AMG 145 reduces LDL cholesterol

Amgen today announced that results from the LAPLACE-TIMI 57 and MENDEL Phase 2 studies evaluating AMG 145 in hypercholesterolemic patients with or without statins, respectively, showed that treatment with AMG 145 resulted in a statistically significant reduction in low-density lipoprotein (LDL) cholesterol.

7 Nov 2012

Takeda, Affymax announce data from OMONTYS Phase 3 studies on anemia due to CKD

Affymax, Inc. and Takeda Pharmaceuticals U.S.A., Inc. (TPUSA) today announced the presentation of post-hoc sub-group analyses of the EMERALD Phase 3 studies that evaluated OMONTYS (peginesatide) Injection, an erythropoiesis-stimulating agent (ESA), for the treatment of anemia due to chronic kidney disease (CKD) in adult dialysis patients.

2 Nov 2012

New data: 4 in 5 children received recommended doses of DTP vaccine during infancy in 2011

Four in five children (83%) worldwide received the recommended three doses of diphtheria-tetanus-pertussis (DTP) vaccine during infancy in 2011, according to new data released in the Morbidity and Mortality Weekly Report and in the WHO Weekly Epidemiological Record (WER).

2 Nov 2012

Adolescent males at increased risk of reporting longtime OTC drug use

As crackdowns get tougher on alcohol, tobacco sales, and illicit drugs, there's a growing trend among youth to turn to another source to get a high: their parent's medicine cabinet. A new University of Cincinnati study suggests adolescent males are at a higher risk of reporting longtime use of over-the-counter drugs, compared with their female peers.

30 Oct 2012

Canadian Cardiovascular Society issues new pediatric heart failure guidelines

The Canadian Cardiovascular Society is the first in Canada to issue guidelines aimed at helping primary care and emergency physicians, as well as specialists, recognize and manage heart failure in children. The guidelines were released today at the Canadian Cardiovascular Congress.

30 Oct 2012

AstraZeneca commences FASLODEX Phase III study for hormone receptor-positive metastatic breast cancer

AstraZeneca today announced the start of a Phase III study (FALCON), a global clinical trial which will involve 450 postmenopausal patients with hormone receptor-positive locally advanced or metastatic breast cancer who have not previously been treated with any hormonal therapy. The Phase III study is designed to evaluate the efficacy and tolerability of fulvestrant 500 mg compared to anastrozole 1 mg in this patient population.

29 Oct 2012

Roundup: New laws on breast screening irk some doctors; Improved school meals cut obesity; More Coloradans use ER

In a sign of the improving national economy, Medicaid spending growth this year slowed to 2 percent as enrollment in the state-federal health insurance program for the poor also slowed for the third consecutive year, according to a report released Thursday. In 2011, Medicaid spending soared by nearly 10 percent, which helped put the entitlement program in the crosshairs of politicians looking to lower the federal deficit and ease pressure on state budgets.

26 Oct 2012

CINJ makes experts available during National Lung Cancer Awareness Month

According to the American Cancer Society, nearly 6,000 new cases of lung cancer are expected to be diagnosed in New Jersey this year, and 4,200 people will die from the disease.

25 Oct 2012

Flu protection: an interview with Dr Gillian SteelFisher of the Harvard School of Public Health in Boston, USA

In 2009, a new strain of influenza, or flu, virus emerged and spread rapidly to many countries around the world. It was declared a pandemic by the World Health Organization (WHO) in June 2009.

24 Oct 2012